John M Limongelli

CIK 1445234 · SVP & General Counsel · last filed 2021-03-19

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.47M

Companies

3

Total Filings

20

Lifetime Open-Market Net

$48.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Neos Therapeutics, Inc. (NEOS) Delisted SVP & General Counsel 0 $1.15 $0 $0 4 2021-03-19
TRVN Sr. VP,General Counsel & CAO 12,000 $0.01 $133 $48.4K 8 2018-03-02
RPRX SVP, General Counsel & Secr 172,500 $54.87 $9.47M $0 4 2010-09-13

Recent Filings · Page 2 of 2

20 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2014-12-15 TRVN Buy (P) +3,000 $12.4K EDGAR
2014-12-10 TRVN Buy (P) +9,000 $36.0K EDGAR
2011-12-14 Mixed −207,450 -$1.50M
2011-08-19 Grant (A) +18,750 $0
2011-06-22 Buy (P) +16,200 $30.5K
2011-06-22 Buy (P) +16,200 $30.5K
2010-09-13 RPRX Grant (A) +112,500 $0 EDGAR
2009-12-17 RPRX Grant (A) +60,000 $0 EDGAR
2009-01-08 RPRX Grant (A) $0 EDGAR
2008-09-19 RPRX Grant (A) $0 EDGAR
Showing 1120 of 20
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.